Amdipharm plc

Regency House, Miles Gray Road, Basildon, Essex, SS14 3AF
Telephone: +44 (0)870 777 7675
Fax: +44 (0)870 777 7875
Medical Information Direct Line: +44 (0)1268 823 049
Medical Information e-mail: medinfo@amdipharm.com
Medical Information Fax: +44 (0)1268 535 287
Summary of Product Characteristics last updated on the eMC: 29/09/2009
SPC Detrunorm XL 30 mg Modified Release Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/09/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   01-Aug-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

The following information has been added or changed:

4.8
Undesirable Effects

2Not Known (cannot be estimated from the available data)

 

- hallucinations

 

Psychiatric

 

 

10. DATE OF REVISION OF THE TEXT

August 2008

Updated on 18/09/2007 and displayed until 29/09/2009
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 18/08/2006 and displayed until 18/09/2007
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
   propiverine hydrochloride


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk